세계의 스마트 인슐린 펜 시장 : 유형별, 사용성별, 용도별, 최종 사용자별-예측(2025-2030년)

The Smart Insulin Pen Market was valued at USD 149.62 million in 2023, expected to reach USD 169.95 million in 2024, and is projected to grow at a CAGR of 14.14%, to USD 377.64 million by 2030.

Smart insulin pens are advanced medical devices designed to aid individuals with diabetes in managing their insulin delivery more effectively by combining traditional insulin injection with smart technology. These pens integrate with mobile applications to track and record insulin doses, provide reminders, and sometimes offer personalized insulin recommendations based on individual glucose levels and trends. The necessity for smart insulin pens arises from the increasing incidence of diabetes worldwide and the demand for more convenient, precise, and user-friendly diabetes management solutions. Their application extends to both Type 1 and Type 2 diabetes patients who require daily insulin administration. The end-use of these devices predominantly spans hospitals, clinics, and home healthcare settings, given the emphasis on patient-centric and cost-effective diabetes management.

In terms of growth factors, the rise in diabetes prevalence, escalating health awareness, and the push towards digital health innovations significantly drive the market. Moreover, the continual enhancement of smart technologies and analytics in healthcare promotes the adoption of these pens. New opportunities are emerging due to the growing demand for integration with other diabetes care systems and the push for more personalized healthcare solutions. However, challenges persist, such as high costs, limited awareness in emerging regions, and regulatory hurdles that can impede market expansion. Privacy concerns regarding data collected by these devices also pose a limitation.

Innovation and research should focus on improving device connectivity, enhancing user interface designs for better patient engagement, and expanding compatibility with a broader range of insulin types and diabetes management apps. Additionally, targeting partnerships with endocrinologists and healthcare providers can facilitate better acceptance and integration into care routines. The market is inherently dynamic, driven by technological advancements and increasing patient demand for convenient and precise diabetes management solutions, suggesting a high potential for growth and evolution in smart insulin pen offerings.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Insulin Pen Market

The Smart Insulin Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in diabetes patients worldwide
  • Emphasis on calculating personalized doses and glucose monitoring
  • Rising acceptance of connected devices and apps for diabetes care in home healthcare settings
• Market Restraints
  • High costs of smart insulin pens
• Market Opportunities
  • Improvements in product offerings with innovative developments
  • Supportive government initiatives and investments for home healthcare solutions
• Market Challenges
  • Limited awareness and technical issues associated with handling smart insulin pens

Porter's Five Forces: A Strategic Tool for Navigating the Smart Insulin Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Insulin Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Insulin Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Insulin Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Insulin Pen Market

A detailed market share analysis in the Smart Insulin Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Insulin Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Insulin Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Smart Insulin Pen Market

A strategic analysis of the Smart Insulin Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Smart Insulin Pen Market, highlighting leading vendors and their innovative profiles. These include B. Braun SE, Becton, Dickinson and Company, Berlin-Chemie AG, Bigfoot Biomedical Inc., BIOCORP Production, Dexcom, Inc., Diamesco Co., Ltd., Eli Lilly and Company, Emperra GmbH, F. Hoffmann-La Roche AG, HTL-Strefa, Inc., Insulet Corporation, IQVIA Inc., Jiangsu Deflu Medical Device Co. Ltd., Medtronic PLC, Novo Nordisk A/S, Owen Mumford Ltd., pendiq GmbH, Sanofi S.A., Tandem Diabetes Care Inc., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Smart Insulin Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across First Generation Pens and Second Generation Pens. The Second Generation Pens is further studied across Bluetooth-Enabled and USB Connected.
• Based on Usability, market is studied across Prefilled and Reusable.
• Based on Application, market is studied across Type I Diabetes and Type II Diabetes.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Home Care Settings, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in diabetes patients worldwide
    • 5.1.1.2. Emphasis on calculating personalized doses and glucose monitoring
    • 5.1.1.3. Rising acceptance of connected devices and apps for diabetes care in home healthcare settings
  • 5.1.2. Restraints
    • 5.1.2.1. High costs of smart insulin pens
  • 5.1.3. Opportunities
    • 5.1.3.1. Improvements in product offerings with innovative developments
    • 5.1.3.2. Supportive government initiatives and investments for home healthcare solutions
  • 5.1.4. Challenges
    • 5.1.4.1. Limited awareness and technical issues associated with handling smart insulin pens
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Second-generation pens offer higher control to diabetes management
  • 5.2.2. Usability: Adoption of reusable smart insulin pens due to its cost-efficiency
  • 5.2.3. Application: Increasing use of smart insulin pens to overcome the burden of Type II diabetes
  • 5.2.4. End-User: Proliferating usage of smart insulin pens in home healthcare settings
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Smart Insulin Pen Market, by Type

• 6.1. Introduction
• 6.2. First Generation Pens
• 6.3. Second Generation Pens
  • 6.3.1. Bluetooth-Enabled
  • 6.3.2. USB Connected

7. Smart Insulin Pen Market, by Usability

• 7.1. Introduction
• 7.2. Prefilled
• 7.3. Reusable

8. Smart Insulin Pen Market, by Application

• 8.1. Introduction
• 8.2. Type I Diabetes
• 8.3. Type II Diabetes

9. Smart Insulin Pen Market, by End-User

• 9.1. Introduction
• 9.2. Ambulatory Surgical Centers
• 9.3. Home Care Settings
• 9.4. Hospitals & Clinics

10. Americas Smart Insulin Pen Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Smart Insulin Pen Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Smart Insulin Pen Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Abbott to Buy Smart Insulin Pen Cap Maker Bigfoot
  • 13.3.2. FDA Clears Mallya Smart Insulin Pen Device from Biocorp
  • 13.3.3. BIOCORP and NOVO NORDISK Strengthen Their Partnership With a New Agreement on Mallya Smart Sensor
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. B. Braun SE
• 2. Becton, Dickinson and Company
• 3. Berlin-Chemie AG
• 4. Bigfoot Biomedical Inc.
• 5. BIOCORP Production
• 6. Dexcom, Inc.
• 7. Diamesco Co., Ltd.
• 8. Eli Lilly and Company
• 9. Emperra GmbH
• 10. F. Hoffmann-La Roche AG
• 11. HTL-Strefa, Inc.
• 12. Insulet Corporation
• 13. IQVIA Inc.
• 14. Jiangsu Deflu Medical Device Co. Ltd.
• 15. Medtronic PLC
• 16. Novo Nordisk A/S
• 17. Owen Mumford Ltd.
• 18. pendiq GmbH
• 19. Sanofi S.A.
• 20. Tandem Diabetes Care Inc.
• 21. Ypsomed Holding AG